Sam Lynch’s BioMimetic Therapeutics becomes Nashville’s first publicly traded biotechnology company when it makes its entrance to the NASDAQ.
The company, headquartered in Lynch’s innovative Cool Springs Life Science Center, specializes in the development and commercialization of products to promote the healing of musculoskeletal injuries and diseases.
